This disconnect is particularly critical in fields like oncology and rare diseases, where timely and precise interventions ...

At the committee meeting, she said that Trump has already axed over 800 grants and billions of dollars in research funding, ...

According to the Elsevier 2024 Gender Equality in Research & Innovation Report, women researchers are well-represented across ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic ...

In its update, GSK reported a 17% rise in specialty medicines across its HIV, cancer, and respiratory business to £2.93 ...

AZ has already thrown down a marker for its tougher stance on Europe, with an earlier decision to abandon a $560 million ...

Abeona Therapeutics' Zevaskyn, a cell therapy based on engineered keratinocytes harvested from patients, has been approved in ...

Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of ...

Reducing levels of LDL-cholesterol can reduce the risk of dementia by 26%, according to a new study, which also suggests statin drugs could provide an additional protective effect. The ...

Johnson & Johnson's third attempt to use bankruptcy proceedings to settle lawsuits claiming that its talc-based products harmed consumers has been rejected. In a Houston, Texas court, Judge ...

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine.

Normally we dedicate this space to agency and consultancy hires, but since we didn’t have any agency hires submitted this month – and we did come across quite a lot of government news – we ...